# Effectiveness and Safety of ArcBlate Palliative Treatment for Patients With Painful Bone Metastases: A Pivotal Study

> **NCT06487013** · NA · RECRUITING · sponsor: **EpiSonica** · enrollment: 100 (estimated)

## Conditions studied

- Bone Metastases

## Interventions

- **DEVICE:** ArcBlate Focused Ultrasound Ablation System
- **OTHER:** Sham MRgHIFU treatment

## Key facts

- **NCT ID:** NCT06487013
- **Lead sponsor:** EpiSonica
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-08
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-09-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06487013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06487013, "Effectiveness and Safety of ArcBlate Palliative Treatment for Patients With Painful Bone Metastases: A Pivotal Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06487013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*